Given vimentin’s role in both the metastasis of cancer cells and susceptibility to bacterial infections, exploring the modulation of vimentin may be a viable strategy for achieving both anticancer and antibacterial therapeutic effects. This evidence concerns the gene VIM and bacterial infectious disease.